RODNEY S. MARKIN, M.D., PH.D

Corporate Board Profile

Tech Score: 0/100

Precipio, Inc.

Filing Date	Source Excerpt
2012-04-20	Rodney S. Markin, M.D., Ph.D, Common Stock Director, Age 55, Chairman of the Board, Transgenomic, Inc., Chief Technology Officer, Associate Vice Chancellor for Business Development. The current members of the Audit Committee are directors Dr. Markin and Dr. Schuh. Dr. Markin currently serves as the Chairman of the Audit Committee. The Compensation Committee currently consists of directors Dr. Schuh, Dr. Markin and Mr. Patzig. Dr. Schuh currently serves as the Chairman of the Compensation Committee. Director Summary Compensation Table: Rodney Markin, M.D., Ph.D. Fees Earned or Paid in Cash ($) 25,375, Option Awards $ 14,568, Total $ 39,943.

Filing Date

Source Excerpt

2012-04-20

Rodney S. Markin, M.D., Ph.D, Common Stock Director, Age 55, Chairman of the Board, Transgenomic, Inc., Chief Technology Officer, Associate Vice Chancellor for Business Development. The current members of the Audit Committee are directors Dr. Markin and Dr. Schuh. Dr. Markin currently serves as the Chairman of the Audit Committee. The Compensation Committee currently consists of directors Dr. Schuh, Dr. Markin and Mr. Patzig. Dr. Schuh currently serves as the Chairman of the Compensation Committee. Director Summary Compensation Table: Rodney Markin, M.D., Ph.D. Fees Earned or Paid in Cash ($) 25,375, Option Awards $ 14,568, Total $ 39,943.

Data sourced from SEC filings. Last updated: 2026-03-05